Related references
Note: Only part of the references are listed.Antibody-mediated rejection after kidney transplantation in children; therapy challenges and future potential treatments
Massimiliano Bertacchi et al.
CLINICAL TRANSPLANTATION (2022)
Assessment of Carfilzomib Treatment Response in Lung Transplant Recipients With Antibody-mediated Rejection
Christine Pham et al.
TRANSPLANTATION DIRECT (2021)
A prospective, iterative, adaptive trial of carfilzomib-based desensitization
Simon Tremblay et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group
Carrie A. Schinstock et al.
TRANSPLANTATION (2020)
Reducing Donor-specific Antibody During Acute Rejection Diminishes Long-term Renal Allograft Loss: Comparison of Early and Late Rejection
Alicia B. Lichvar et al.
TRANSPLANTATION (2020)
Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials
Somedeb Ball et al.
ANNALS OF HEMATOLOGY (2020)
Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients
Despina Fotiou et al.
BLOOD CANCER JOURNAL (2020)
Managing highly sensitized renal transplant candidates in the era of kidney paired donation and the new kidney allocation system: Is there still a role for desensitization?
Carrie A. Schinstock et al.
CLINICAL TRANSPLANTATION (2019)
Efficacy and toxicity profile of carfilzomib based regimens for treatment of multiple myeloma: A systematic review
Adeela Mushtaq et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (ARROW): interim analysis results of a randomised, phase 3 study
Philippe Moreau et al.
LANCET ONCOLOGY (2018)
The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis
Susan S. Wan et al.
TRANSPLANTATION (2018)
Targeting the Proteasome in Refractory Pediatric Leukemia Cells: Characterization of Effective Cytotoxicity of Carfilzomib
Lucy Swift et al.
TARGETED ONCOLOGY (2018)
Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma
Rimda Wanchoo et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Prospective Iterative Trial of Proteasome Inhibitor-Based Desensitization
E. S. Woodle et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Proteasome inhibitor therapy for antibody-mediated rejection
E. S. Woodle et al.
PEDIATRIC TRANSPLANTATION (2011)
Early and Late Acute Antibody-Mediated Rejection Differ Immunologically and in Response to Proteasome Inhibition
R. Carlin Walsh et al.
TRANSPLANTATION (2011)
Pediatric end stage renal disease health-related quality of life differs by modality: a PedsQL ESRD analysis
Stuart L. Goldstein et al.
PEDIATRIC NEPHROLOGY (2009)
Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection
Matthew J. Everly et al.
TRANSPLANTATION (2008)
Share Paper
